CA3106447A1 — Substituted heterocycle fused gamma-carbolines synthesis
Assigned to Intra Cellular Therapies Inc · Expires 2019-12-19 · 6y expired
What this patent protects
The present invention provides a compound of Formula 1J: wherein R is H or methyl, and Q is selected from 4-(4-fluorophenyl)-4-oxobutyl, in free or salt form; a composition comprising Formula 1J; and an improved method for the preparation of Formula 1J or Formula 1J in pharmaceut…
USPTO Abstract
The present invention provides a compound of Formula 1J: wherein R is H or methyl, and Q is selected from 4-(4-fluorophenyl)-4-oxobutyl, in free or salt form; a composition comprising Formula 1J; and an improved method for the preparation of Formula 1J or Formula 1J in pharmaceutically acceptable form.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.